Monday, February 25, 2019 2:34:34 PM
So good Doctor Rushton exactly WHEN, WHO, and WHERE sir? How about advising the CEO making the 'accredited partners' public info? That would lend a pound of credibility to the share price of the company instead of being in the dark.
"Fully licensed and accredited partners"...
"However, the truly exciting developments for modern cannabis-based products are in the medical field,” explained Dr. Paul Rushton, Vice President of Biotechnology at 22nd Century Group (XXII) “Cannabis is a treasure trove of bio-active molecules that scientists have only just begun.."
” Dr. Rushton, explained. “With a sizeable head-start in low-THC Cannabis sativa research in collaboration with the Company’s fully licensed and accredited partners, 22nd Century (XXII) Is poised to take advantage of hemp’s new legal status and to develop and commercialize new hemp/cannabis varieties for the medical and agricultural fields.”
December 2018
"Fully licensed and accredited partners"...
"However, the truly exciting developments for modern cannabis-based products are in the medical field,” explained Dr. Paul Rushton, Vice President of Biotechnology at 22nd Century Group (XXII) “Cannabis is a treasure trove of bio-active molecules that scientists have only just begun.."
” Dr. Rushton, explained. “With a sizeable head-start in low-THC Cannabis sativa research in collaboration with the Company’s fully licensed and accredited partners, 22nd Century (XXII) Is poised to take advantage of hemp’s new legal status and to develop and commercialize new hemp/cannabis varieties for the medical and agricultural fields.”
December 2018
Recent XXII News
- 22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review • GlobeNewswire Inc. • 05/12/2026 05:50:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 10:30:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 10:06:10 AM
- 22nd Century Group Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/07/2026 10:00:00 AM
- 22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026 • GlobeNewswire Inc. • 05/04/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 09:20:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/01/2026 09:15:15 PM
- 22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership • GlobeNewswire Inc. • 04/29/2026 08:35:00 PM
- 22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University • GlobeNewswire Inc. • 04/23/2026 11:50:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/13/2026 04:15:24 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:35:13 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:30:36 PM
- 22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/31/2026 09:00:54 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/27/2026 08:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 12:02:51 PM
- 22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/26/2026 10:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/24/2026 05:57:09 PM
- 22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026 • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 09:14:20 PM
- 22nd Century Group Reports Continued Early Sales Momentum for VLN® Cigarette Products • GlobeNewswire Inc. • 02/23/2026 10:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:15:28 PM
- 22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/20/2026 09:15:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 04:59:02 PM
